Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Getting the diagnosis right: beyond El Escorial.

V Meininger1

  • 1Hôpital de la Salpétrière, Division Mazarin, Paris, France. vincent.meininger@psl-ap-hop-paris.fr

Journal of Neurology
|January 13, 2000
PubMed
Summary

This paper discusses the ongoing challenges in diagnosing early-stage amyotrophic lateral sclerosis (ALS). Despite the development of the El Escorial criteria in 1990 and their revision in 1998, diagnosing ALS remains difficult, especially in its early stages. The authors review historical case reports and diagnostic guidelines to understand why early diagnosis is still unclear. They find that the variability in how ALS presents clinically complicates accurate diagnosis. The study does not propose new diagnostic methods but highlights the need for clearer definitions and improved diagnostic tools. The authors suggest that refining current criteria could help improve early detection and management of ALS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of amyotrophic lateral sclerosis.

Revue neurologique·2017
Same author

A decrease in blood cholesterol after gastrostomy could impact survival in ALS.

European journal of clinical nutrition·2017
Same author

[TBK1 gene stresses the major role of autophagy in ALS].

Revue neurologique·2015
Same author

A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.

European journal of neurology·2014
Same author

[Analysis of clinical pathway in changing and disabling neurological diseases].

Revue neurologique·2013
Same author

Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations.

Neurology·2012

Area of Science:

  • Neurological diagnostics
  • Amyotrophic lateral sclerosis (ALS) research
  • Clinical neurology

Background:

Amyotrophic lateral sclerosis (ALS) remains a challenging condition to diagnose early. Over a century after its initial description by Charcot, neurologists still find it difficult to distinguish ALS from other neurological disorders in its early stages. The El Escorial criteria, developed in 1990 by the World Federation of Neurology (WFN), have provided a diagnostic framework for ALS. These criteria were revised in 1998 to improve their utility. Despite these efforts, the early diagnostic process remains unclear. This uncertainty persists due to the complex and variable presentation of ALS in clinical settings. Prior research has shown that diagnostic accuracy is crucial for effective disease management. However, the lack of clarity in defining early-stage ALS complicates treatment decisions. This gap motivated the need for a more nuanced understanding of how ALS has been historically documented and diagnosed.

Purpose Of The Study:

The purpose of this paper is to explore the historical development of diagnostic approaches to ALS, particularly focusing on the El Escorial criteria. The study aims to clarify why early-stage ALS remains difficult to define and diagnose. By reviewing case reports and diagnostic guidelines, the authors seek to highlight the challenges in early diagnosis. The motivation stems from the ongoing uncertainty among neurologists regarding ALS classification. The study does not propose new diagnostic criteria but instead analyzes existing literature to identify diagnostic hurdles. The goal is to provide insight into the evolution of ALS diagnosis and its current limitations. This analysis is intended to inform future diagnostic strategies and improve clinical decision-making. The paper does not introduce new methodologies but synthesizes existing knowledge to address unresolved questions.

Keywords:
ALS diagnosisneurological disordersEl Escorial guidelinesclinical neurology

Frequently Asked Questions

Early-stage ALS is difficult to diagnose due to overlapping symptoms with other neurological conditions.

The El Escorial criteria have improved diagnostic consistency but have not resolved early-stage ambiguity.

Historical case reports help identify diagnostic patterns and inconsistencies in early ALS classification.

The study suggests that current diagnostic tools remain insufficient for early-stage ALS detection.

Related Experiment Videos

Main Methods:

The authors employed a review approach, analyzing case reports and diagnostic guidelines published in the literature. This method allowed them to trace the historical progression of ALS diagnosis. The focus was on the El Escorial criteria and their revisions. The study included a chronological examination of how diagnostic criteria have evolved since Charcot’s initial description. The authors did not conduct original experiments or collect new data. Instead, they synthesized existing information to identify patterns and inconsistencies. The review approach emphasized the diagnostic challenges faced by clinicians. By examining how ALS has been documented over time, the authors aimed to highlight diagnostic ambiguities. This synthesis provides a framework for understanding the limitations of current diagnostic standards.

Main Results:

The study found that the El Escorial criteria have improved diagnostic consistency but have not resolved early-stage ambiguity. The authors observed that diagnostic accuracy remains low in the initial phases of ALS. The literature review revealed that early-stage ALS is often misdiagnosed due to overlapping symptoms with other neurological conditions. The study also noted that the revised criteria have not fully addressed the variability in clinical presentation. The authors found that case reports frequently highlight diagnostic uncertainty. The synthesis of historical data suggests that defining early ALS remains a significant challenge. The results indicate that diagnostic tools have not yet fully captured the heterogeneity of ALS. These findings underscore the need for continued refinement of diagnostic approaches.

Conclusions:

The authors conclude that the El Escorial criteria have not yet provided a definitive solution to early-stage ALS diagnosis. They emphasize that the variability in clinical presentation complicates accurate diagnosis. The study highlights the importance of historical case reports in understanding diagnostic challenges. The authors suggest that further refinement of diagnostic criteria is necessary to improve early detection. They do not propose new diagnostic methods but stress the need for clearer definitions of early-stage ALS. The synthesis of literature indicates that current diagnostic tools remain insufficient. The authors propose that a better understanding of early-stage symptoms could improve diagnostic accuracy. These conclusions align with the study’s aim to clarify the ongoing difficulties in diagnosing ALS.

Diagnostic variability complicates accurate diagnosis due to differences in clinical presentation.

The authors propose refining diagnostic criteria to better capture early-stage symptoms.